Yichen Sun Selected Research

trametinib

10/2021

Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yichen Sun Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 09/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 12/2017
2	Parkinson Disease (Parkinson's Disease) 01/2024 - 07/2023
2	Nasopharyngeal Carcinoma 10/2023 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2021
2	Adenocarcinoma 05/2020 - 12/2017
2	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 12/2008
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Rectal Neoplasms (Rectal Cancer) 02/2024
1	Cholangiocarcinoma 11/2023
1	Carcinogenesis 11/2023
1	Autism Spectrum Disorder 10/2023
1	Rheumatoid Arthritis 10/2023
1	Hyperplasia 10/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Pneumonia (Pneumonitis) 11/2022
1	COVID-19 11/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2021
1	Fibrosis (Cirrhosis) 04/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2018

Drug/Important Bio-Agent (IBA)

2	ChromatinIBA 02/2024 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2023
2	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2023 - 09/2021
2	Histone Deacetylase InhibitorsIBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2020
2	Gemcitabine FDA Link 10/2022 - 12/2017
1	nardilysinIBA 04/2024
1	Phosphotransferases (Kinase)IBA 04/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	Circular RNAIBA 01/2024
1	NeuroliginsIBA 10/2023
1	EnzymesIBA 10/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023
1	statticIBA 08/2023
1	ProteomeIBA 07/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Polycomb Repressive Complex 2IBA 01/2023
1	Medical Waste DisposalIBA 11/2022
1	Medical Waste (Waste, Medical)IBA 11/2022
1	ThrombomodulinIBA 10/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2022
1	Heroin (Diamorphine)IBA 01/2022
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022
1	Mitogen-Activated Protein KinasesIBA 10/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021
1	trametinibIBA 10/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	Long Noncoding RNAIBA 05/2020
1	Topotecan (Hycamtin)FDA LinkGeneric 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	AntimonyIBA 09/2018
1	PotassiumIBA 09/2018
1	tartaric acid (tartrate)FDA Link 09/2018
1	Peptides (Polypeptides)IBA 12/2017
1	EndostatinsIBA 12/2008
1	endostar proteinIBA 12/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 10/2023 - 09/2018
2	Therapeutics 11/2023 - 01/2022
1	Neoadjuvant Therapy 02/2024
1	Physical Therapy Modalities (Physical Therapy Technique) 10/2023
1	Lasers (Laser) 12/2008